Definium Therapeutics Inc. Stock Performance
as on July 18, 2026 at 2:16 pm IST
Day's Low
Day's High
$43.38$45.18
2.05%
Downside
2.01%
Upside
52 Week's Low
52 Week's High
100.00%
Downside
-100.00%
Upside
Definium Therapeutics Inc. share price movements today
- Previous Close
- $44.10
- Open
- $43.51
- Volume
- 927.6K
- Day's Low - High
- $43.38 - $45.18
Definium Therapeutics Inc. Historical Returns
- 1 Month Return
- + 80.92 %
- 3 Month Return
- + 95.28 %
- 1 Year Return
- 0 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Definium Therapeutics Inc. Stock Fundamentals & Key Indicators
Check Definium Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$5.8B
EPS (TTM)
-2.2325
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-94.70%
Definium Therapeutics Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Definium Therapeutics Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| NA | $5.8B | NA | NA | 0.00% | NA | |
| BUY | $38.1B | 524.49% | NA | 0.00% | NA | |
| BUY | $123.4B | 140.09% | 28.32 | 35.51% | NA | |
| BUY | $71.2B | 16.02% | 16.23 | 29.65% | 0.54% |
Indian Investors' Interest in Definium Therapeutics Inc. Stock
Investment in Definium Therapeutics Inc. Shares on INDmoney has grown by 582.35% in the last 30 days, indicating increased investment activity.
Time period: to
Change:582.35% versus previous 30 day period
Search interest for Definium Therapeutics Inc. Stock has increased by 747% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:747% versus previous 30 day period
Definium Therapeutics Inc. Quarterly Profit & Loss
All numbers in Millions USD
Definium Therapeutics Inc. Annual Profit & Loss
All numbers in Millions USD
Definium Therapeutics Inc. Quarterly Cash Flow
All numbers in Millions USD
Definium Therapeutics Inc. Annual Cash Flow
All numbers in Millions USD
Definium Therapeutics Inc. News & Key Events
Today's Timeline - 22 June
Mon, 04:42 PM
-Definium Therapeutics announces positive Phase 3 results for DT120 ODT in major depressive disorder, showing significant efficacy.
Insights on Definium Therapeutics Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, DFTX has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, DFTX has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 1 month, DFTX stock has moved up by 80.9%
About Definium Therapeutics Inc.
| Organisation | Definium Therapeutics Inc. |
| Headquarters | One World Trade Center, New York, NY, United States, 10007 |
| Industry | Biotechnology |
| CEO | Mr. Robert Barrow |
| E-voting on shares | Click here to vote |
Key Management of Definium Therapeutics Inc.
Name | Title |
|---|---|
Dr. Daniel Rollings Karlin M.A., M.D. | Chief Medical Officer |
Mr. Peter Mack | Senior Vice President of Pharmaceutical Development & Operations |
Ms. Gitanjali Jain Ogawa | VP & Head of Investor Relations |
Mr. Mark R. Sullivan J.D. | Chief Legal Officer & Corporate Secretary |
Mr. Robert Barrow | CEO & Director |
Ms. Brandi L. Roberts CPA, M.B.A. | Chief Financial Officer |
Ms. Beth Calitri | Vice President of Corporate Communications |
Ms. Stephanie Fagan M.S. | Chief Corporate Affairs Officer |
Dr. Scott M. Freeman M.D. | Co-Founder & Clinical Advisor |
Mr. Leonard Latchman | Co-Founder |
FAQs
What is Definium Therapeutics Inc. share price today?
Definium Therapeutics Inc. share price today is $44.29 as on at the close of the market. Definium Therapeutics Inc. share today touched a day high of $45.18 and a low of $43.38.
What is the 52 week high and 52 week low for Definium Therapeutics Inc. share?
Definium Therapeutics Inc. share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Definium Therapeutics Inc. stock price today i.e. is closed at $44.29,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.
What is Definium Therapeutics Inc.'s market capitalisation today?
Definium Therapeutics Inc. market capitalisation is $0.01T as on .
How to invest in Definium Therapeutics Inc. Stock (DFTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Definium Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Definium Therapeutics Inc. Shares that will get you 0.0339 shares as per Definium Therapeutics Inc. share price of $44.29 per share as on July 18, 2026 at 8:46 am IST.
What is the minimum amount required to buy Definium Therapeutics Inc. Stock (DFTX) from India?
Indian investors can start investing in Definium Therapeutics Inc. (DFTX) shares with as little as ₹96.28 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹962.80 in Definium Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Definium Therapeutics Inc. share’s latest price of $44.29 as on July 18, 2026 at 8:46 am IST, you will get 0.2258 shares of Definium Therapeutics Inc.. Learn more about
fractional shares .